logologo
QuantliQuantli

Lexeo Therapeutics Inc

LXEO

NASDAQ

Biotechnology

$4.84

USD

-0.12 (-2.42%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $363.56M

Volume 676.6K

Price Target

$9.00$9.00

USD

The 1 analysts offering 1-year price forecasts have a max estimate of $9.00 and a min estimate of $9.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$9.00

-$8.0 vs prior

Implied Upside

+86.0%

-165.3% vs prior

Analyst Covering

1

Unchanged vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

50%

A mix of recent and older ratings shape this consensus

Analyst Agreement

High

Targets are closely clustered - analysts largely agree

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

1 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

1 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Tessa Romero

JP Morgan

Buy

Maintained

1 month ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

CAPR

Capricor Therapeutics Inc

$6.65

+58.0%

FENC

Fennec Pharmaceuticals Inc

$11.72

-2.8%

PRLD

Prelude Therapeutics Inc

$5.55

+3.5%

RCKT

Rocket Pharmaceuticals Inc

$3.47

+3.9%

EDIT

Editas Medicine Inc

$2.82

+0.4%

ENTA

Enanta Pharmaceuticals Inc

$13.16

-2.1%

PROK

Prokidney Corp

$1.33

-5.3%

BNTC

Benitec Biopharma Inc

$12.56

0.0%

CMPX

Compass Therapeutics Inc.

$2.25

-0.4%